Biopharma | June 22, 2026
Happiest Health to host Ayurveda & Gut Dialogue on June 29
The event is expected to bring together health and wellness enthusiasts for an afternoon of insights, learning and practical takeaways
The event is expected to bring together health and wellness enthusiasts for an afternoon of insights, learning and practical takeaways
The sale is part of a broader strategy to streamline its asset footprint and concentrate investment on core growth areas
The new facility will produce precision extruded medical tubing used in minimally invasive medical devices
The expanded approval covers children and teens with chronic conditions that increase vulnerability to pneumococcal infections
The collaboration is focused on overcoming a major limitation in existing cancer drugs
Company becomes sole first applicant for 45 mg strength, positioning itself for potential 180-day generic exclusivity in the US market
New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones
Seasoned pharmaceutical R&D leader takes on an expanded leadership role to drive innovation and strengthen Hetero’s advanced formulation development capabilities
Backs Lifesigns in first bet and doubles down on India’s healthcare AI surge
Over 28 crore people screened, TB incidence falls sharply as Centre urges states to intensify efforts ahead of July campaign deadline
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
